Treatment of alopecia areata with sulfasalazine [8]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 4, 2007, Pages 547-548

  Misery, Laurent ^a   Sannier, K ^a   Chastaing, M ^a   Le Gallic, G ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MINOXIDIL; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ALOPECIA AREATA; ASTHENIA; CASE REPORT; DISEASE DURATION; DIZZINESS; DRUG DOSE INCREASE; DRUG WITHDRAWAL; HAIR GROWTH; HEADACHE; HUMAN; LETTER; OUTPATIENT CARE; PRIORITY JOURNAL; PUVA; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADULT; ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EYELASHES; HAIR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SULFASALAZINE;

EID: 33947358518     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01945.x     Document Type: Letter

References (3)

1. Misery L, Rousset H. La pelade est-elle une maladie psychosomatique? Rev Med Interne 2001; 22: 274-279.
2. Smedegard G, Bjork K. Sulphasalazine: Mechanism of action in rheumatoid arthritis. Br Soc Rheumatol 1995; 34s: 7-15.
3. Ellis CN, Brown MF, Voorhees JJ. Sulfasalazine for alopecia areata. J Am Acad Dermatol 2002; 46: 541-544.